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PCardiac Imaging
revalence of Noncalcified
oronary Plaques by 64-Slice
omputed Tomography in Patients With an
ntermediate Risk for Significant Coronary Artery Disease
örg Hausleiter, MD,* Tanja Meyer, MD,† Martin Hadamitzky, MD,* Adnan Kastrati, MD,*
tefan Martinoff, MD,† Albert Schömig, MD*
unich, Germany
OBJECTIVES In this prospective study, we investigated the prevalence and characteristics of clearly
discernible noncalcified coronary plaques in a patient population with suspected significant
coronary artery disease (CAD) by using 64-slice computed tomography (CT).
BACKGROUND The assessment of noncalcified coronary plaques by noninvasive strategies may be important
to improve cardiovascular risk stratification.
METHODS To rule out significant stenosis, high-resolution 64-slice coronary CT (0.6-mm collimation,
330-ms gantry rotation time) was performed in 161 consecutive patients with an intermediate
risk for having CAD. Computed tomography data sets were evaluated for presence of
coronary calcifications, noncalcified plaques, and/or lumen narrowing.
RESULTS Noncalcified coronary plaques were detected in 48 (29.8%) of 161 enrolled patients. Although
noncalcified plaques together with coronary calcifications were present in 38 of 161 (23.6%)
patients, the prevalence of noncalcified plaques as the only manifestation of CAD was 6.2%
(10 of 161 patients). Patients with noncalcified plaques were characterized by significantly
higher total cholesterol, low-density lipoprotein, and C-reactive protein levels as well as a
trend for more diabetes mellitus. The majority of noncalcified plaques resulted in lumen
narrowing of 50%. Of the remaining 113 patients, CAD and coronary calcifications were
ruled out in 53 of 161 (32.9%) patients, whereas 60 of 161 (37.3%) patients presented with
calcifications in the absence of noncalcified plaque.
CONCLUSIONS With the use of 64-slice CT, clearly discernible noncalcified atherosclerotic coronary plaques
can be detected in a large group of patients with an intermediate risk for having CAD. The
assessment of these plaques by CT angiography may allow for improved cardiovascular risk
stratification. (J Am Coll Cardiol 2006;48:312–8) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.02.064Cardiology Foundation
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Pcute coronary syndromes, including sudden coronary
eath, frequently are caused by plaque erosion, ulceration, or
upture. The term “vulnerable plaque” has been introduced
o define plaques susceptible to such ischemic complications
1). A large number of vulnerable plaques are predominantly
oncalcified and nonstenotic and similar to type IV athero-
clerotic lesions described in the American Heart Associa-
ion classification (2). Type IV lesions are characterized by
See page 319
xtracellular lipid accumulations also known as lipid cores.
hese lipid cores dramatically increase intimal wall shear
tress compared with fibrous tissue and calcifications (3),
endering lipid-rich atherosclerotic plaques by far more
nstable and vulnerable to sudden rupture than other types
From the *Klinik für Herz- und Kreislauferkrankungen and the †Institut für
adiologie und Nuklearmedizin, Deutsches Herzzentrum München; Klinik an der
U München, Munich, Germany.c
Manuscript received August 31, 2005; revised manuscript received January 20,
006, accepted February 14, 2006.f lesions. The detection of such vulnerable plaques remains
difficult task; invasive techniques, among others intravas-
ular ultrasound (4), optical coherence tomography (5),
laque thermography (6), and angioscopy (7), have been
sed to describe markers of plaque vulnerability. Noninva-
ive imaging techniques such as high-resolution computed
omography are considered as promising new methodolo-
ies with the potential to detect vulnerable patients.
Recent reports have demonstrated the ability of contrast-
nhanced multislice computed tomography (MSCT) to
etect noncalcified atherosclerotic plaque (8–11). However,
he prevalence of noncalcified plaque detected by 64-slice
omputed tomography (CT) has never been systematically
valuated. Therefore, we prospectively studied the preva-
ence and characteristics of noncalcified plaque visualized
ith an enhanced spatial resolution of 64-slice CT in
atients with suspected coronary artery disease (CAD).
ETHODS
atients. From October 2004 through January 2005, 161
onsecutive patients with an intermediate risk for having
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July 18, 2006:312–8 Noncalcified Plaque Detection by 64-Slice CTAD were referred to our interdisciplinary cardioradiologic
SCT laboratory. The intermediate risk for having signif-
cant CAD was defined as: 1) chest pain or dyspnea in the
resence of negative stress tests; 2) the absence of chest pain
ut positive stress tests; or 3) the absence of chest pain and
f positive stress tests but intermittent arrhythmias. Intermit-
ent arrhythmias were defined as exercise-induced premature
entricular complexes during bicycle stress testing, short runs of
onsustained ventricular tachycardias during Holter electrocar-
iography (ECG) monitoring (e.g., 3 consecutive beats), or
ntermittent atrial arrhythmias with increasing frequency
ithin the last year. Patients were excluded who had: 1) known
AD; 2) chest pain in combination with positive tests for
yocardial ischemia; or 3) arrhythmias that did not allow
CG-triggering of the MSCT scan. All study related data,
ncluding patient history, current medication, and laboratory
esults, as well as MSCT related data and results were
ollected prospectively in a dedicated coronary MSCT
eporting system with the use of Oracle database. The
lobal risk of myocardial infarction was estimated with the
se of the Prospective Cardiovascular Münster (PROCAM)
tudy scoring system (12).
SCT. Patients with a heart rate 60 beats/min received
etoprolol 5 to 20 mg intravenously before the MSCT scan
Sensation 64 Cardiac, Siemens Medical Solutions, Erlangen,
ermany). Coronary vasodilatation was achieved by the ad-
inistration of nitroglycerin 0.8 mg sublingually before the
can to obtain a maximum opacification of the coronary
rteries. A native scan without contrast dye was performed
o determine the total calcium burden of the coronary tree
sequential scan with 32  0.6-mm collimation, tube
urrent 60 mAs at 120 kV). Contrast-enhanced CT angiog-
aphy data were acquired with the use of a spiral scan with
2  0.6-mm collimation, 330-ms gantry rotation, pitch of
.2, and tube voltage at 120 kV. A total of 64 overlapping
.6-mm slices per rotation were acquired with the use of a
ocal spot periodically moving in the longitudinal direction
z-flying focal spot) (13). This sampling scheme results in
n improved spatial resolution which is identical to that of
64  0.3-mm detector (0.4  0.4  0.4-mm isotropic
esolution). Tube current was modulated according to the
CG, with a maximum current of 850 to 950 mAs during
time period of approximately 330 ms centered at 375 ms
efore the next R-wave and reduction by 80% during the
Abbreviations and Acronyms
ASE  Agatston score equivalent
CAD  coronary artery disease
CRP  C-reactive protein
CT  computed tomography
IQR  interquartile range
LDL  low-density lipoprotein
MSCT  multislice computed tomography
PROCAM  Prospective Cardiovascular Münster scoreemaining cardiac cycle (14). In our cardiovascular MSCT sesearch laboratory, the estimated effective dose associated
ith cardiac 64-slice CT angiography was estimated to be
1.0  4.1 mSv. Contrast agent (60 to 80 ml; 350 mg
odine/ml) was injected intravenously (4.5 to 5.0 ml/s).
ransaxial images were reconstructed using an ECG-gated
alf-scan reconstruction algorithm (temporal resolution 164
s) and kernel B30f. In case of a heart rate of 65
eats/min, a bisegmental reconstruction algorithm is ap-
lied that uses data obtained from two consecutive heart-
eats, reducing the effective reconstruction interval per heart
ycle down to 83 ms, depending on the heart rate. The
osition of the reconstruction window within the cardiac
ycle was individually optimized to minimize motion
rtifacts.
SCT image interpretation. Vessel wall calcifications
ere quantified on a separate workstation (Wizard, Siemens
edical Solutions), based on the standard built-in algo-
ithm using an Agatston score equivalent (ASE) adapted for
SCT. Two reviewers independently evaluated the
ontrast-enhanced MSCT scans by assessment of the axial
lices, of multiplanar reformations and of three thin-slab
aximum intensity projections. Orientated along the heart
xis, the thin-slab (5-mm thickness, 1-mm increment)
aximum intensity projections were reconstructed perpen-
icular to each other. The coronary artery tree was seg-
ented according to modified American Heart Association
lassification (15) and the segments were investigated for
umen narrowing. Segments were graded as small (diameter
1.5mm), normal appearing (stenosis grade 0% to 24%),
lightly narrowed (stenosis grade 25% to 49%), moderately
arrowed (stenosis grade 50% to 74%), and severely nar-
owed (stenosis grade 75%).
The presence of noncalcified atherosclerotic plaque tissue
as defined as any discernible structure in the coronary
rtery wall with a CT density less than the contrast-
nhanced coronary lumen but greater than the surrounding
onnective tissue. For the determination of plaque density
alues, the respective coronary segment was rendered and
isplayed in orthogonal views (0.6-mm thick slices) accord-
ng to the vessel axis. Measurements were obtained from
anually traced regions of interests encompassing the non-
alcified plaque proportions. These tracings were drawn as
arge as possible but avoiding the borders of adjacent
tructures to limit the effect of interpolation and partial
olume on the measurements. Calcified plaque components
f mixed plaques (combined noncalcified and calcified
laque tissues) were excluded from the assessment of the
oncalcified plaque density. Standard display settings were
sed for the evaluation of the contrast-enhanced MSCT
cans (window width 800 Hounsfield units [HU]; window
enter 250 HU).
nvasive coronary angiography. Invasive coronary angio-
rams were evaluated by two independent and experienced
nvestigators cardiologist that were unaware of the results of
he CT examination. Stenosis severity in each coronary
egment was classified according to the maximal luminal
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Noncalcified Plaque Detection by 64-Slice CT July 18, 2006:312–8iameter stenosis present in each segment. Lesions were
xamined in orthogonal views, and stenosis severity was
isually determined using a similar grading system as with
SCT image interpretation.
tatistical analysis. Continuous variables are expressed as
edian (interquartile range [IQR]) and compared by means
f Mann-Whitney U test; discrete variables are expressed as
ounts or percentages and compared with chi-square or the
isher exact test (whenever an expected cell value was 5).
tatistical significance was accepted for p  0.05.
ESULTS
coronary MSCT investigation was performed in 161
atients. A dose of 15 mg (IQR 10, 20) of metoprolol was
dministered in 124 (77.0%) patients to lower the heart rate,
hich resulted in a mean heart rate of 57 beats/min (IQR
3, 81) beats/min during scanning.
No coronary calcifications were present in 63 of 161
39%) patients, whereas calcified plaques were determined
n 98 of 161 (61%) patients (Fig. 1). Subsequent contrast-
nhanced coronary CT angiography revealed the presence
f noncalcified plaques in 10 (16%) of the 63 patients who
ad no coronary calcifications. In these patients, noncalci-
ed plaques were the only manifestation of CAD. The
verall prevalence of patients with noncalcified plaques as
he only manifestation of CAD was 6.2% (10 of 161
atients). In patients with coronary calcifications, additional
oncalcified plaques were detected in 38 of 98 (39%)
atients, whereas 60 of 98 (61%) patients were free of
oncalcified plaques by CT angiography. In summary,
AD because of the presence of calcified or noncalcified
laques, was detected in a total of 108 patients. Table 1
ummarizes the characteristics of patients with and without
AD. Patients without CAD were significantly younger
nd presented with a lower cardiovascular risk profile,
esulting in a lower 10-year risk for a cardiovascular event byFigure 1. Prevalence of calcified and noncalcified plaques in the study grohe PROCAM score. Accordingly, less cardiovascular med-
cations were taken by patients without CAD.
Noncalcified plaques, alone or in combination with cal-
ifications, were observed in 48 (44%) of 108 patients with
AD (30% of all 161 studied patients). Patients with
oncalcified plaques were characterized by significantly
igher total cholesterol and low-density lipoprotein (LDL)
evels as well as a trend of having more diabetes mellitus.
urthermore, the inflammatory marker C-reactive protein
CRP) was significantly increased in patients with noncal-
ified plaques. In contrast, patients with noncalcified
laques did not differ with respect to most traditional
ardiovascular risk factors, including age, gender, body mass
ndex, arterial hypertension, smoking as well as the esti-
ated 10-year cardiovascular risk by the PROCAM score.
lthough there were no differences in the rates of beta-
lockers, angiotensin-converting enzyme inhibitors, diuret-
cs as well as Ca2-antagonists, the use of statins was
ignificantly lower in patients with noncalcified plaques.
able 2 summarizes the clinical characteristics of patients
ith and without the presence of noncalcified plaques in
ore detail. The MSCT investigation revealed that patients
ith noncalcified plaques tend to have fewer coronary
alcifications than patients without noncalcified plaques
ASE: 80 [IQR 9, 246] vs. 170 [IQR 17, 554] for patients
ith vs. without noncalcified plaques; p  0.12). Figure 2
resents a CT angiogram in a 52-year-old male patient who
resented with chest pain. A large noncalcified plaque is
isualized in the proximal left anterior descending coronary
rtery, which was the only manifestation of CAD in this
atient.
Noncalcified coronary plaques were identified in a total of
7 coronary segments (1.6  1.1 segments per patient,
ange 1 to 5). A total of 34 of 77 (44%) segments revealed
ompletely noncalcified plaques whereas 43 of 77 (56%)
egments had mixed plaques with calcified and noncalcifiedup. CAD  coronary artery disease; CT  computed tomography.
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July 18, 2006:312–8 Noncalcified Plaque Detection by 64-Slice CTomponents. The majority of these plaques (68%) resulted
n a lumen narrowing of50% with a predominant location
n the left anterior descending coronary artery in 51% (39 of
7 noncalcified plaques). The median density values of the
oncalcified plaques were 68 HU (IQR 51 to 87 HU).
Invasive coronary angiography was performed in 23
atients with noncalcified plaques by CT angiography. A
otal of 40 noncalcified plaques were present in these
atients. One-half of these plaques resulted in minor wall
rregularities with a maximum stenosis grade of 25% by
nvasive angiography. Nonsignificant stenosis with lumen
arrowing between 25% and 50% were observed in addi-
ional nine noncalcified plaques. The remaining 11 noncal-
ified plaques resulted in high-grade lumen narrowing and
ere treated by using percutaneous coronary intervention.
ISCUSSION
ipid-rich coronary plaques have been associated with an
ncreased vulnerability for sudden plaque rupture, leading to
cute ischemic coronary syndromes. The ability to detect
hese plaques at early stages by a noninvasive methodology
ould probably improve risk stratification of these patients.
his prospective study indicates that such noncalcified
oronary plaques, alone or in combination with calcifica-
ions, can be detected in a high proportion of patients
nvestigated by 64-slice CT angiography for suspected
Table 1. Clinical Characteristics of Patients W
Clinical characteristics
Age, yrs
Male gender
Body mass index, kg/m2
Arterial hypertension
Active smoker
Diabetes mellitus
Family history of CAD
Cholesterol, mg/dl
LDL, mg/dl
HDL, mg/dl
Triglyceride, mg/dl
CRP, mg/l
10-yr risk for coronary event with PROCAM scor
Indication for CTA
Chest pain or dyspnea
Positive stress test
Intermittent arrhythmia
Current medication
Antiplatelet drugs
Statins
Beta-blocker
ACE inhibitor or ATl-receptor antagonist
Ca2 antagonist
Diuretics
Data are n (%) or median [interquartile range].
ACE  angiotensin-converting enzyme; CAD  corona
tomography angiography; HDL  high-density lipoprotei
Cardiovascular Münster.AD. These patients were characterized by higher total lholesterol, LDL, and CRP levels and by a trend of
aving more diabetes mellitus. Furthermore, this study
emonstrates that noncalcified coronary plaques were the
nly manifestation of CAD in 6% of the study population
or in 16% of patients with a negative score for coronary
alcifications).
The identification of patients at increased risk for an
schemic and potentially fatal cardiac event is a difficult task
n cardiovascular medicine. Despite extensive studies and
evelopment of several risk prediction models, traditional
ardiovascular risk factors fail to predict development of
AD in a large group of patients (16). A stepwise approach
or risk stratification has been proposed recently. The
roposed noninvasive tools range from self-questionnaire to
olecular plaque imaging. Multislice computed tomogra-
hy angiography has been introduced as noninvasive tech-
ique for the reliable detection of coronary stenosis in
ddition to the quantification of calcified plaque burden
17,18). With the improved spatial resolution, CT angiog-
aphy also allows for the detection of noncalcified coronary
laques. Compared with intravascular ultrasound, the sen-
itivity and specificity of 16-slice CT for the detection of
oncalcified plaques, alone or in combination with calcified
laques, has been described at approximately 78% and 87%
o 92%, respectively (10,11). Coronary plaques not detected
y 16-slice CT had a smaller plaque thickness and were
nd Without Coronary Artery Disease
Without CAD
(n  53)
With CAD
(n  108) p Value
52 [41, 62] 61 [54, 69] 0.001
30 (56.6) 82 (75.9) 0.012
24.5 [22.7, 26.6] 26.3 [24.1, 29.2] 0.002
23 (43.4) 81 (75.0) 0.001
9 (17.0) 26 (24.1) 0.31
0 (0) 16 (14.8) 0.002
20 (37.7) 32 (29.6) 0.30
209 [190, 237] 214 [190, 247] 0.47
121 [104, 153] 128 [106, 151] 0.48
61 [51, 71] 54 [43, 63] 0.015
111 [79, 157] 144 [92, 205] 0.005
0.9 [0.5, 2.1] 1.3 [0.5, 3.2] 0.26
1.0 [0.4, 4.0] 6.2 [2.2, 11.9] 0.001
0.10
35 (66) 60 (56)
6 (11) 28 (26)
12 (23) 20 (18)
6 (11.3) 35 (32.4) 0.004
12 (22.6) 30 (39.8) 0.030
16 (30.2) 44 (40.7) 0.19
11 (20.8) 52 (48.1) 0.001
3 (5.7) 10 (9.3) 0.65
4 (7.5) 12 (16.7) 0.17
ery disease; CRP  C-reactive protein; CTA  computed
L  low-density lipoprotein; PROCAM  Prospectiveith a
e
ry artocated in smaller coronary arteries (10). With the enhanced
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Noncalcified Plaque Detection by 64-Slice CT July 18, 2006:312–8patial resolution of approximately 0.4 mm with 64-slice
T technology a further improvement in noncalcified
laque detection could be expected.
In the current study, we studied the prevalence of
oncalcified plaques in a population of consecutive patients
ith suspected CAD by 64-slice CT angiography. This
atient population is believed to have the largest benefit of
oninvasive MSCT angiography (17,18). In the current
tudy, the MSCT findings allowed for a separation of the
opulation into three groups: 1) CAD was ruled out in
Table 2. Clinical Characteristics of Patients W
W
Clinical characteristics
Age, yrs
Male gender
Body mass index, kg/m2
Arterial hypertension
Active smoker
Diabetes mellitus
Family history of CAD
Cholesterol, mg/dl
LDL, mg/dl
HDL, mg/dl
Triglyceride, mg/dl
CRP, mg/l
10-yr risk for coronary event with
PROCAM score
Indication for CTA
Chest pain or dyspnea
Positive stress test
Intermittent arrhythmia
Current medication
Antiplatelet drugs
Statins
Beta-blocker
ACE inhibitor or AT1-receptor antagonist
Ca2 antagonist
Diuretics
Data are n (%) or median [interquartile range].
Abbreviations as in Table 1.
igure 2. Coronary computed tomography angiogram in a 52-year-old ma
large nonstenotic and noncalcified plaque is visualized in the proximal lef
f coronary artery disease in this patient. In the cross-sectional image o
ontrast-filled lumen and the surrounding connective tissue. The density measur
8 HU.pproximately one-third of studied patients; 2) CAD with
oronary stenosis and/or calcifications but without noncal-
ified plaques was present in another third of investigated
atients; and 3) approximately one-third of patients pre-
ented with noncalcified plaques alone or in combination
ith coronary calcifications. In this study, noncalcified
laques were defined as clearly discernible structures with
ensity values less than the contrast-enhanced lumen but
reater than the surrounding connective tissue. Diffuse
oncalcified plaques, which may result in blurred contours
nd Without Noncalcified Plaques
t Noncalcified
es (n  60)
With Noncalcified
Plaques (n  48) p Value
[55.8, 69] 61.0 [53, 67] 0.48
(75.0) 37 (77.0) 0.80
[24.5, 29.2] 25.6 [24.2, 28.9] 0.48
(73.3) 37 (77.0) 0.65
(21.7) 13 (27.1) 0.51
(10.0) 10 (20.8) 0.12
(30.0) 14 (29.2) 0.92
[183, 224] 231 [204, 255] 0.003
[94, 137] 140 [112, 171] 0.008
[48, 63] 52 [42, 62] 0.21
[89, 202] 163 [105, 216] 0.22
[0.5, 2.8] 1.7 [0.7, 4.0] 0.045
[1.7, 11.9] 6.4 [3.6, 12.8] 0.24
0.71
(60) 25 (52)
(22) 13 (27)
(18) 10 (21)
(40.0) 11 (22.9) 0.059
(50.0) 13 (27.1) 0.016
(43.3) 18 (37.5) 0.54
(53.3) 20 (41.7) 0.28
(8.3) 5 (10.4) 0.71
(20.0) 6 (12.5) 0.30
ient who presented with chest pain. In the long-axis reconstruction (left),
rior descending (LAD) coronary artery, which was the only manifestation
LAD (right), the noncalcified plaque can be clearly depicted from theith a
ithou
Plaqu
61.0
45
26.9
44
13
6
18
202
121
54
142
1.0
6.4
36
13
11
24
30
26
32
5
12le pat
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f theements within the plaque revealed a predominantly lipid-rich plaque with
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July 18, 2006:312–8 Noncalcified Plaque Detection by 64-Slice CTf the contrast-enhanced lumen, and small noncalcified
laques, were not included in this analysis. Therefore, the
resence of noncalcified plaques will be underestimated
ompared with histologic postmortem studies. Of interest,
atients with noncalcified plaques had higher total choles-
erol, LDL, as well as CRP levels. The significantly higher
RP values in patients with noncalcified plaque are of
articular interest. No association between CRP and the
alcified plaque burden was found in the SIRCA (Study of
nherited Risk of Coronary Atherosclerosis) (19). In con-
rast, our study demonstrates that elevated CRP values
orrelate with earlier noncalcified stages of atherosclerotic
laque development. This finding supports the association
f the inflammatory burden with increased cardiovascular
isk (20).
The definition of clearly discernible noncalcified plaques
ay allow for the improved detection of patients at higher
isk for subsequent cardiovascular ischemic events. In fact,
n this population with suspected CAD, noncalcified
laques were the only manifestation of CAD in 10 (6.2%) of
61 studied patients; when related to patients in whom no
alcifications were detectable by CT, the frequency of
oncalcified plaques as the only manifestation of CAD was
onsiderably higher (10 of 63 [16%] patients). The assess-
ent of traditional cardiovascular risk factors in combina-
ion with CT scanning for coronary calcifications may have
ailed to identify this patient population with a potentially
igher cardiovascular risk. Therefore, noncalcified plaque
etection by coronary CT angiography may have an additive
rognostic value, particularly in patients with an ASE of 0.
he absence of coronary calcifications has been described in
.7% male patients with significant coronary stenosis (21)
nd in 4% patients suffering from an unheralded myocardial
nfarction (22). Although the precise mechanisms and the
omposition of plaques causing a myocardial infarction are
argely unknown, it is hypothesized that predominantly
ipid-rich coronary plaques are more rupture-prone than
brous-rich plaques. In the current study we identified a
otal of 77 noncalcified plaques (or 1.6 plaques/patients)
ith a median plaque density of 68 HU (IQR 51 to 87 HU).
lthough the accuracy of the assessment of plaque densities
ay be influenced by several factors, among others, the
recise definition of noncalcified plaque contours, the in-
raluminal attenuation of contrast dye, as well as the used
onvolution kernel, these results suggest that a large number
f detected noncalcified plaques may contain more hypo-
ense structures such as lipid accumulations. However,
urther studies are needed to validate CT modalities for the
ssessment of coronary plaque composition before a clear
ifferentiation into lipid- or fibrous-rich plaques is possible.
Clearly, the risk for ischemic events in patients with
oncalcified plaques as well as the additive value of noncal-
ified plaque detection over traditional calcium scoring is
urrently not known. Therefore, long-term follow-up stud-
es in larger populations are needed to further investigate the
mpact of noncalcified plaque detection by MSCT onardiovascular events on top of the traditional assessments
f cardiovascular risk factors and coronary calcifications.
urthermore, strategies for the prevention of cardiovascular
vents in patients with detected noncalcified plaques remain
o be evaluated. The visualization of noncalcified plaque by
SCT is limited by plaque and vessel size; therefore,
maller plaques predominantly located in smaller coronary
rteries will no be accurately identified by currently available
T scanner generations. Finally, the possible benefits of
oncalcified plaque detection by CT angiographies need to
e weighed against the potential hazards associated with the
adiation dose delivered to the chest.
In conclusion, high-resolution 64-slice CT angiography
llows for the detection of discernible noncalcified coronary
laques in a large group of patients with suspected CAD.
hese findings may improve risk stratification of patients
usceptible for an ischemic cardiovascular event. However,
urther data on the prognostic impact of these noncalcified
laques are needed before their assessment by coronary CT
ngiography can be recommended for clinical decision
aking and risk stratification.
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